Remifentanil and cyclooxygenase inhibitors interactions in the minimum alveolar concentration of sevoflurane in the rat

British Journal of Anaesthesia

Volumn 105, Issue 6, 2010, Pages 810-817

  Benito, J ^a,c   Aguado, D ^a   Abreu, M B ^b   Garcia Fernandez J ^b   Gomez De Segura I A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

anaesthetics volatile, sevoflurane; analgesics opioid, remifentanil; complications, drug tolerance; model, rat; pain, acute

Indexed keywords

DIPYRONE; DIPYRONE MAGNESIUM; KETOPROFEN; PARACETAMOL; PARECOXIB; REMIFENTANIL; SEVOFLURANE;

ANIMAL EXPERIMENT; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD CARBON DIOXIDE TENSION; CONTINUOUS INFUSION; DIASTOLIC BLOOD PRESSURE; DRUG MEGADOSE; DRUG POTENTIATION; DRUG TOLERANCE; HEART RATE; INHALATION ANESTHESIA; LOW DRUG DOSE; LUNG GAS EXCHANGE; MALE; MEAN ARTERIAL PRESSURE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; SYSTOLIC BLOOD PRESSURE;

EID: 78649456774     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeq241     Document Type: Article

References (50)

1. Santos M, Kunkar V, Garcia-Iturralde P, Tendillo FJ. Meloxicam, a specific COX-2 inhibitor, does not enhance the isoflurane minimum alveolar concentration reduction produced by morphine in the rat. Anesth Analg 2004; 98: 359-63
2. Gomez de Segura IA, Criado AB, Santos M, Tendillo FJ. Aspirin synergistically potentiates isoflurane minimum alveolar concentration reduction produced by morphine in the rat. Anesthesiol-ogy 1998; 89: 1489-94
3. Eger EI, Saidman LJ, Brandstater B. Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology 1965; 26: 756-63
4. Docquier MA, Lavand'homme P, Ledermann C, Collet V, De Kock M. Can determining the minimum alveolar anesthetic concentration of volatile anesthetic be used as an objective tool to assess antinociception in animals? Anesth Analg 2003; 97: 1033-9
5. Olofsen E, Sleigh JW, Dahan A. The influence of remifentanil on the dynamic relationship between sevoflurane and surrogate anesthetic effect measures derived from the EEG. Anesthesiology 2002; 96: 555-64
6. Turner PV, Kerr CL, Healy AJ, Taylor WM. Effect of meloxicam and butorphanol on minimum alveolar concentration of isoflurane in rabbits. Am J Vet Res 2006; 67: 770-4
7. Yamashita K, Okano Y, Yamashita M, Umar MA, Kushiro T, Muir WW. Effects of carprofen and meloxicam with or without butorphanol on the minimum alveolar concentration of sevoflur-ane in dogs. J Vet Med Sci 2008; 70: 29-35
8. Ko JC, Lange DN, Mandsager RE, et al. Effects of butorphanol and carprofen on the minimal alveolar concentration of isoflurane in dogs. J Am Vet Med Assoc 2000; 217: 1025-8
9. Gomez de Segura IA, Benito de la Vibora J, Aguado D. Opioid tolerance blunts the reduction in the sevoflurane minimum alveolar concentration produced by remifentanil in the rat. Anesthesiology 2009; 110: 1133-8
10. Hutchinson MR, Coats BD, Lewis SS, et al. Proinflammatory cyto-kines oppose opioid-induced acute and chronic analgesia. Brain Behav Immun 2008; 22: 1178-89
11. Fu D, Guo Q, Ai Y, Cai H, Yan J, Dai R. Glial activation and segmen-tal upregulation of interleukin-1b (IL-1b) in the rat spinal cord after surgical incision. Neurochem Res 2006; 31: 333-40
12. Kroin JS, Ling ZD, Buvanendran A, Tuman KJ. Upregulation of spinal cyclooxygenase-2 in rats after surgical incision. Anesthe-siology 2004; 100: 364-9
13. Abbott FV, Hellemans KGC. Phenacetin, acetaminophen and dipyrone: analgesic and rewarding effects. Behav Brain Res 2000; 112: 177-86
14. Cooper DM, Hoffman W, Tomlinson K, Lee HY. Refinement of the dosage and dosing schedule of ketoprofen for postoperative analgesia in Sprague-Dawley rats. Lab Anim (NY) 2008; 37: 271-5
15. Padi SSV, Jain NK, Singh S, Kulkarni SK. Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor. Eur J Pharmacol 2004; 491: 69-76
16. Mazario J, Herrero JF. Antinociceptive effects of metamizol (dipyr-one) in rat single motor units. Neurosci Lett 1999; 274: 179-82
17. Carlsson KH, Helmreich J, Jurna I. Activation of inhibition from the periaqueductal grey matter mediates central analgesic effect of metamizol (dipyrone). Pain 1986; 27: 373-90
18. Hernandez-Delgadillo GP, Cruz SL. Dipyrone potentiates morphine-induced antinociception in dipyrone-treated and morphine-tolerant rats. Eur J Pharmacol 2004; 502: 67-73
19. Abbott FV, Bonder M. Options for management ofacute paininthe rat. Vet Rec 1997; 140: 553-7.
20. Criado AB, Gomez de Segura IA. Reduction of isoflurane MAC by fentanyl or remifentanil inrats. Vet Anaesth Analg 2003; 30: 250-6
21. Ammon S, von Richter O, Hofmann U, Thon KP, Eichelbaum M, Mikus G. In vitro interaction of codeine and diclofenac. Drug Metab Dispos 2000; 28: 1149-52
22. Doherty TJ, Will WA, Rohrbach BW, Geiser DR. Effect of morphine and flunixin meglumine on isoflurane minimum alveolar concentration in goats. Vet Anaesth Analg 2004; 31: 97-101
23. Ko JC, Weil AB, Inoue T. Effects of carprofen and morphine on the minimum alveolar concentration of isoflurane in dogs. J Am Anim Hosp Assoc 2009; 45: 19-23
24. Malmberg AB, Yaksh TL. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 1993; 79: 270-81
25. Rampil IJ, King BS. Volatile anesthetics depress spinal motor neurons. Anesthesiology 1996; 85: 129-34
26. Steffey EP, Baggot JD, Eisele JH, et al. Morphine-isoflurane interaction in dogs, swine and rhesus monkeys. J Vet Pharmacol Ther 1994; 17: 202-10
27. Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, Shafer SL. Remi-fentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthe-siology 1996; 84: 821-33
28. Haidar SH, Moreton JE, Liang Z, Hoke JF, Muir KT, Eddington ND. Evaluating a possible pharmacokinetic interaction between remi-fentanil and esmolol in the rat. J Pharm Sci 1997; 86: 1278-82
29. Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004; 56: 387-437
30. Anderson BJ. Paracetamol (Acetaminophen): mechanisms of action. Paediatr Anaesth 2008; 18: 915-21
31. Watanabe C, Okuda K, Sakurada C, Ando R, Sakurada T, Sakurada S. Evidence that nitric oxide-glutamate cascade modulates spinal antinociceptive effect of morphine: a behavioural and microdialysis study in rats. Brain Res 2003; 990: 77-86
32. Vaughan CW, Ingram SL, Connor MA, Christie MJ. How opioidsinhibit GABA-mediated neurotransmission. Nature 1997; 390: 611-4
33. Miranda HF, Prieto JC, Pinardi G. Spinal synergy between nonse-lective cyclooxygenase inhibitors and morphine antinociception in mice. Brain Res 2005; 1049: 165-70
34. Pinardi G, Prieto JC, Miranda HF. Analgesic synergism between intrathecal morphine and cyclooxygenase-2 inhibitors in mice. Pharmacol Biochem Behav 2005; 82: 120-4
35. Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998; 104: 413-21
36. Cheer SM, Goa KL. Parecoxib (parecoxib sodium). Drugs 2001; 61: 1133-41
37. Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J 2008; 22: 383-90
38. Kis B, Snipes JA, Gaspar T, Lenzser G, Tulbert CD, Busija DW. Cloning of cyclooxygenase-1b (putative COX-3) in mouse. Inflamm Res 2006; 55: 274-8
39. Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002; 99: 13926-31
40. Kis B, Snipes JA, Busija DW. Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties. J Pharmacol Exp Ther 2005; 315: 1-7
41. Srikiatkhachorn A, Tarasub N, Govitrapong P. Acetaminophen-induced antinociception via central 5-HT(2A) receptors. Neurochem Int 1999; 34: 491-8
42. Courade JP, Chassaing C, Bardin L, Alloui A, Eschalier A. 5-HT receptor subtypes involved in the spinal antinociceptive effect of acetaminophen in rats. Eur J Pharmacol 2001; 432: 1-7
43. Jeong CY, Choi JI, Yoon MH. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. Eur J Pharmacol 2004; 502: 205-11
44. Ottani A, Leone S, Sandrini M, Ferrari A, Bertolini A. The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. Eur J Pharmacol 2006; 531: 280-1
45. Shavit Y, Wolf G, Goshen I, Livshits D, Yirmiya R. Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance. Pain 2005; 115: 50-9
46. Vinik HR, Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 1998; 86: 1307-11
47. Cortinez LI, Brandes V, Munoz HR, Guerrero ME, Mur M. No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia. Br J Anaesth 2001; 87: 866-9
48. Lee LH, Irwin MG, Lui SK. Intraoperative remifentanil infusion does not increase postoperative opioid consumption compared with 70% nitrous oxide. Anesthesiology 2005; 102: 398-402
49. Hutchinson MR, Bland ST, Johnson KW, Rice KC, Maier SF, Watkins LR. Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. Sci World J 2007; 7: 98-111
50. Watkins LR, Hutchinson MR, Johnston IN, Maier SF. Glia: novel counter-regulators of opioid analgesia. Trends Neurosci 2005; 28: 661-9